Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
NCT06150703 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 652
Last updated 2025-08-24
Summary
The development of stimulation protocols for in vitro fertilisation (IVF) has led to a paradox. It has now been established that obtaining a large number of oocytes is a key to success, but that it is also a risk factor for embryo transfer failure after puncture (disruption of endometrial receptivity due to luteal insufficiency) and a risk factor for complications such as ovarian hyperstimulation syndrome (OHSS).
Conditions
- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection
Interventions
- DRUG
-
Ovulation induction with hCG + Luteal phase support with vaginal progesterone
hCG 250µg subcutaneously between 36h and 38h before oocyte retrieval + Progesterone 600mg/d (200mg morning, noon and evening) vaginally from the evening of the puncture until the pregnancy test result
- DRUG
-
Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
Triptorelin 0.2 mg subcutaneously between 36h and 38h before oocyte retrieval as a single dose Nafarelin 400µg /day (200µg in the morning 200µg in the evening) nasally from the evening of the oocyte retrieval until the first pregnancy test
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-27
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-27
Countries
- France
Study Locations
More Related Trials
-
Luteal Phase Support In IVF Women Using GnRH Agonist
NCT04174378 ·Status: COMPLETED
-
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
NCT00954811 ·Status: UNKNOWN ·Phase: PHASE4
-
Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days
NCT01093443 ·Status: COMPLETED ·Phase: PHASE4
-
Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day
NCT02397551 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
NCT02357654 ·Status: RECRUITING ·Phase: PHASE4
-
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
NCT02330770 ·Status: RECRUITING ·Phase: PHASE4
-
GnRH Agonist as Luteal Support in FET Cycles
NCT02620124 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
NCT02053779 ·Status: COMPLETED ·Phase: PHASE3
-
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
NCT02827656 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
NCT02312076 ·Status: RECRUITING ·Phase: PHASE4
-
GnRH Agonist at Embryo Transfer: IVF Outcomes
NCT03544073 ·Status: WITHDRAWN ·Phase: PHASE3
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles
NCT00516490 ·Status: COMPLETED ·Phase: NA
-
Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial
NCT04087408 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
NCT04008966 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Trigger Versus Booster Dose of HCG
NCT02397642 ·Status: COMPLETED ·Phase: NA
-
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG
NCT01638026 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH Agonist and Intrauterine Insemination
NCT00503217 ·Status: COMPLETED ·Phase: PHASE4
-
Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days
NCT01468441 ·Status: COMPLETED ·Phase: NA
-
Trigger Timing in Ovarian Stimulations
NCT04163133 ·Status: RECRUITING ·Phase: NA
-
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
NCT03039049 ·Status: COMPLETED ·Phase: PHASE3
-
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
NCT07128394 ·Status: RECRUITING ·Phase: NA
-
Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.
NCT00365027 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes
NCT01979341 ·Status: WITHDRAWN ·Phase: NA